Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Liquidia Corp (LQDA)

Liquidia Corp (LQDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 939,471
  • Shares Outstanding, K 84,637
  • Annual Sales, $ 17,490 K
  • Annual Income, $ -78,500 K
  • EBIT $ -112 M
  • EBITDA $ -109 M
  • 60-Month Beta 0.22
  • Price/Sales 51.25
  • Price/Cash Flow N/A
  • Price/Book 8.11

Options Overview Details

View History
  • Implied Volatility 64.25% ( -4.48%)
  • Historical Volatility 42.44%
  • IV Percentile 26%
  • IV Rank 19.55%
  • IV High 137.51% on 05/14/24
  • IV Low 46.45% on 09/20/24
  • Put/Call Vol Ratio 0.28
  • Today's Volume 657
  • Volume Avg (30-Day) 1,039
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 70,116
  • Open Int (30-Day) 67,225

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.39
  • Number of Estimates 6
  • High Estimate -0.26
  • Low Estimate -0.49
  • Prior Year -0.42
  • Growth Rate Est. (year over year) +7.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.93 +11.78%
on 11/21/24
11.79 -5.85%
on 12/05/24
+0.98 (+9.68%)
since 11/20/24
3-Month
9.71 +14.32%
on 11/19/24
11.84 -6.23%
on 10/16/24
+1.15 (+11.56%)
since 09/20/24
52-Week
8.26 +34.38%
on 08/19/24
16.99 -34.67%
on 03/22/24
+0.40 (+3.74%)
since 12/20/23

Most Recent Stories

More News
Insider Sale: Chief Commercial Officer of $LQDA (LQDA) Sells 546 Shares

Scott Moomaw, the Chief Commercial Officer of $LQDA ($LQDA), sold 546 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.4%...

LQDA : 11.10 (+4.82%)
Insider Sale: General Counsel of $LQDA (LQDA) Sells 1,063 Shares

Russell Schundler, the General Counsel of $LQDA ($LQDA), sold 1,063 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.2% of...

LQDA : 11.10 (+4.82%)
Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

LQDA : 11.10 (+4.82%)
Liquidia to Present at the Stifel 2024 Healthcare Conference

LQDA : 11.10 (+4.82%)
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024

LQDA : 11.10 (+4.82%)
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024

LQDA : 11.10 (+4.82%)
United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent

LQDA : 11.10 (+4.82%)
ANAVASI DIAGNOSTICS ANNOUNCES NEWLY ELECTED OUTSIDE BOARD OF DIRECTORS

/PRNewswire/ -- Anavasi Diagnostics ('Anavasi'), an NIH/RADx medical technology company focused on the development of novel molecular diagnostic testing,...

LQDA : 11.10 (+4.82%)
CYAN : 0.3005 (-24.88%)
Why Liquidia Stock Rocketed Nearly 21% Higher Today

Investors were obviously cheered by a round of insider buying.

LQDA : 11.10 (+4.82%)
UTHR : 359.58 (-0.16%)
Why Liquidia Shares Rose 18.4% on Monday

Optimism by the company regarding a patent ruling is encouraging investors.

LQDA : 11.10 (+4.82%)
UTHR : 359.58 (-0.16%)

Business Summary

Liquidia Technologies, Inc. is a late-stage clinical biopharmaceutical company. It focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. The company's product candidate consists of LIQ861 for the treatment of...

See More

Key Turning Points

3rd Resistance Point 12.09
2nd Resistance Point 11.65
1st Resistance Point 11.38
Last Price 11.10
1st Support Level 10.67
2nd Support Level 10.23
3rd Support Level 9.96

See More

52-Week High 16.99
Fibonacci 61.8% 13.66
Fibonacci 50% 12.63
Fibonacci 38.2% 11.59
Last Price 11.10
52-Week Low 8.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar